Tocqueville Asset Management L.P. Ligand Pharmaceuticals Inc Transaction History

Tocqueville Asset Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$105.93 - $142.47 $484,206 - $651,230	-4,571 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$128.36 - $272.13 $24,773 - $52,521	193 Added 4.41%	4,571 $620,000
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $526,471 - $684,303	-2,493 Reduced 36.28%	4,378 $1.2 Million
Q2 2018 Aug 13, 2018	BUY	$150.77 - $207.98 $34,827 - $48,043	231 Added 3.48%	6,871 $1.42 Million
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $218,480 - $287,809	-1,576 Reduced 19.18%	6,640 $1.1 Million
Q4 2017 Feb 13, 2018	SELL	$128.36 - $147.04 $2.51 Million - $2.87 Million	-19,550 Reduced 70.41%	8,216 $1.13 Million
Q3 2017 Oct 30, 2017	BUY	$120.91 - $137.94 $3.36 Million - $3.83 Million	27,766	27,766 $3.78 Million

257

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.89B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.